Markets:

Overview

News

Currencies

International

Treasuries

Cellectis S.A. - American Depositary Shares (NQ:CLLS)

3.750 +0.090 (+2.46%)

Streaming Delayed Price Updated: 4:00 PM EST, Mar 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cellectis S.A. - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

Cellectis Announces 2026 Strategy and Catalysts

January 08, 2026

From Cellectis Inc.

Via GlobeNewswire

Traders are paying attention to the gapping stocks in Monday's session. ↗

December 29, 2025

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.

Via Chartmill

Allogene Therapeutics Reports Favorable Result for Servier in Arbitration with Cellectis

December 15, 2025

From Allogene Therapeutics, Inc.

Via GlobeNewswire

Cellectis Earnings Preview ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For August 4, 2025 ↗

August 04, 2025

Via Benzinga

Cellectis Announces Arbitral Decision in Dispute with Servier

December 15, 2025

From Cellectis Inc.

Via GlobeNewswire

ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL

December 08, 2025

From Cellectis Inc.

Via GlobeNewswire

Why Cellectis Stock Is Trading Higher Today ↗

November 19, 2025

Cellectis reports strong Nature Communications data showing CssDNA boosts non-viral gene insertion efficiency and supports long-term therapeutic potential.

Via Benzinga

European ADRs Navigate Choppy Waters: Pharma Sector Shows Resilience Amidst Broader Market Volatility

November 19, 2025

European American Depositary Receipts (ADRs) have recently experienced a period of significant fluctuation, reflecting a broader climate of market volatility that has ripple across global financial...

Via MarketMinute

Cellectis Publishes Nature Communications Article on a Non-Viral Gene Editing Process Enabling Efficient Gene Insertion in Hematopoietic Stem Cells

November 19, 2025

From Cellectis Inc.

Via GlobeNewswire

Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update

November 07, 2025

From Cellectis Inc.

Via GlobeNewswire

Earnings Scheduled For November 7, 2025 ↗

November 07, 2025

Via Benzinga

Cellectis to Present a Development Update for eti-cel at ASH 2025

November 03, 2025

From Cellectis Inc.

Via GlobeNewswire

Cellectis to Report Third Quarter Financial Results on November 7, 2025

October 31, 2025

From Cellectis Inc.

Via GlobeNewswire

Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

October 20, 2025

Via Benzinga

Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL

October 16, 2025

From Cellectis Inc.

Via GlobeNewswire

Thursday's session: gap up and gap down stocks ↗

October 16, 2025

Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday ↗

October 16, 2025

Via Benzinga

Top 2 Health Care Stocks That May Keep You Up At Night This Month ↗

October 16, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

October 16, 2025

The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.

Via Chartmill

Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers

October 16, 2025

From Cellectis Inc.

Via GlobeNewswire

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress

October 07, 2025

From Cellectis Inc.

Via GlobeNewswire

Wondering what's happening in today's pre-market session? ↗

September 29, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 29, 2025

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The market value of their outstanding shares is at $10.5 million.

Via Benzinga

Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

September 29, 2025

U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Monday. Shares of Inventiva ADR (NASDAQ: IVA) fell sharply in today's pre-market trading following H1...

Via Benzinga

Topics Stocks

Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket ↗

September 29, 2025

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 19, 2025

Via Benzinga

Top 5 Biotech Stocks With Strong Momentum ↗

August 28, 2025

Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.

Via Benzinga

Cellectis Reports Second Quarter 2025 Financial Results & Business Updates

August 04, 2025

From Cellectis Inc.

Via GlobeNewswire

Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

July 29, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.